Cheng et al. demonstrated that knocking down the expression of the SIX1 gene increased the expression of DACH1 [33], thereby activating the expression of p53 and inhibiting the progression of HCC cells in vivo and in vitro. The gene discussed is SIX1; the disease is hepatocellular carcinoma.